225Ac-LNC1011

DRUG2 trials

Sponsors

First Affiliated Hospital of Fujian Medical University

Conditions

Prostate Cancer

Phase 1

Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Active, not recruitingNCT07117760

First Affiliated Hospital of Fujian Medical UniversityProstate Cancer

Start: 2025-04-22End: 2029-12-31Updated: 2026-04-29

Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

RecruitingNCT07363486

First Affiliated Hospital of Fujian Medical UniversityProstate Cancer

Start: 2025-04-01End: 2027-12-31Target: 9Updated: 2026-01-23